欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/V/0252/002
药品名称LIBEO 40 MG CHEWABLE TABLETS FOR DOGS
活性成分
    • furosemide 40.0 mg
剂型Chewable tablet
上市许可持有人SOGEVAL
参考成员国 - 产品名称France (FR)
13486
互认成员国 - 产品名称
    • Germany (DE)
      Libeo 40 mg
    • Denmark (DK)
    • Belgium (BE)
      Libeo 40 mg
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
      Libeo 40mg Chewable Tablets for Dogs
    • Austria (AT)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Libeo 40 mg cheweable tablets for dogs
    • Czechia (CZ)
    • Romania (RO)
许可日期2013/10/23
最近更新日期2024/06/04
药物ATC编码
    • QC03CA01 furosemide
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase